Clinical Trials Logo

Clinical Trial Summary

Developmental dyslexia affects 7% of school-age children (Male:Female ratio of 1.5:1) and incurs disadvantages in education and occupation. Scientific progress concerning the etiology of developmental dyslexia evidenced the complex gene-environment interaction. The DCDC2-READ1 deletion associates with reading skills and affects the magnocellular-dorsal stream in humans and animals. DCDC2 modifies neural activity within the excitatory pathways. The magnocellular-dorsal stream mediates the function of the attention network. Difficulties in spatial and temporal attention shifting impair letter-to-speech sound integration increasing neural noise. Action video games improve the efficiency of the magnocellular-dorsal stream. The aim of this cutting-edge, round trip translation study is threefold: 1.to unravel new insights behind the pathophysiology of developmental dyslexia, 2. to assess gene-environment interaction effects on developmental dyslexia endophenotypes, and 3. to identify useful clues to foster the identification of new, personalized treatments.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06186882
Study type Interventional
Source IRCCS Eugenio Medea
Contact Sara Mascheretti
Phone 031877895
Email sara.mascheretti@lanostrafamiglia.it
Status Recruiting
Phase N/A
Start date April 30, 2023
Completion date April 30, 2026

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06213272 - Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits N/A
Active, not recruiting NCT04113707 - Building Long-term Academic Success Through Ongoing Fun Fitness Program N/A
Completed NCT05137353 - A Multisensory Music Intervention for Children With Reading Disorders (RitMoZ) N/A
Active, not recruiting NCT02107534 - Group-based Training for Parents of Children With Dyslexia N/A
Completed NCT00191906 - Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) Phase 4